Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

U.S. and European investigators describe agents for CNS disorders

Feb. 11, 1997

Spiro compounds for CNS disorders disclosed by Takeda

Feb. 11, 1997

BioSpecifics Technologies is issued 9th U.S. patent for use of collagenase enzyme

Feb. 10, 1997

Launch date for Aricept revealed

Feb. 10, 1997

Analgesic/antiinflammatory agent from Merck KGaA

Feb. 10, 1997

Gruenenthal prepares analgesics

Feb. 10, 1997

Potential anticonvulsant described by CoCensys

Feb. 7, 1997

Abbott's newest dopaminergic compounds described in patent literature

Feb. 6, 1997

Pierre Fabre antidepressant approved in France

Feb. 5, 1997

Pineal gland-specific gene-1 disclosed by HGS

Feb. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...